EU-funded scientists are researching an innovative treatment that grafts dopamine cells into the brains of patients with Parkinson’s Disease that could substantially improve their lives.
TRANSEURO, an EU-funded research project, has set itself the ambitious aim to help improve the quality of life of patients diagnosed with Parkinson’s Disease. To do this, it is studying patients with a relatively young onset of the disease and their tolerance to an innovative treatment which involves transplanting fetal ventral mesencephalic tissue.